Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Martlet Capital is an early-stage venture capital firm founded in 2011 and based in Cambridge, UK. The firm focuses on providing patient capital to startups in the deep technology and life sciences sectors, particularly those with high growth potential. Since its inception, Martlet Capital has invested in over 70 startups, achieving notable exits including Abcam and Cambridge CMOS Sensors. The operational business of Martlet Capital is owned and managed by EMV Capital, which acquired it in May 2024, ensuring continuity in its investment strategy and brand.
Martlet Capital has a portfolio valued at approximately £23.3 million, encompassing 53 active companies. The firm has established itself as a key player in the Cambridge startup ecosystem, known for its commitment to supporting B2B startups that demonstrate strong technological foundations and defensible market positions. The firm’s strategic guidance and access to a robust network enhance its portfolio companies' chances of success.
Martlet Capital primarily invests in pre-seed and seed stage companies, concentrating on sectors such as artificial intelligence, digital health, genomics, robotics, and sustainable technologies. The firm seeks to support entrepreneurs by providing not only capital but also strategic guidance and operational support. Investments typically start at £250,000, targeting companies that exhibit potential for rapid growth and possess a strong intellectual property position.
The investment thesis emphasizes the importance of deep technology and life sciences, particularly within the Cambridge ecosystem. Martlet Capital aims to identify startups that can leverage innovative technologies to solve complex problems in their respective fields. The firm’s approach includes a thorough evaluation of the founding team’s capabilities and the startup's market potential, ensuring alignment with their investment strategy.
Martlet Capital has built a diverse portfolio of companies across various sectors, including:
These companies represent a mix of successful exits and ongoing ventures, showcasing Martlet Capital's commitment to fostering innovation in high-growth sectors.
Dr. Ilian Iliev - Director at Martlet Capital, with a background in managing investments in deep tech and life sciences. He has extensive experience in evaluating startup potential and guiding entrepreneurs.
Tom Hall - Investment Director, responsible for sourcing and managing investments. He has a strong track record in identifying high-potential startups in the UK.
Robert Marshall - Non-Executive Chairman and founder of Martlet Capital, known for his credibility in the deep tech startup space.
Amy Weatherup - Advisor with expertise in operational support for startups, providing insights into scaling businesses effectively.
Dr. Iris Good - Advisor specializing in life sciences, offering guidance on navigating the complexities of this sector.
Pete Hutton - Advisor with a focus on technology commercialization and market entry strategies.
To pitch to Martlet Capital, founders should submit a concise slide deck via email to contactus@martletcap.com. The deck should include an overview of the business, market opportunity, competitive landscape, and financial projections. Martlet Capital prefers clear and direct communication, highlighting the startup's unique aspects and growth potential.
Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are beneficial but not mandatory.
In May 2024, EMV Capital acquired the operational business of Martlet Capital, allowing for continued management of its portfolio valued at approximately £23.3 million across 53 companies. This acquisition aims to enhance Martlet's investment strategy while preserving its brand.
Martlet Capital has been recognized as a leading seed-stage investor in deep tech and life sciences, with multiple successful exits, including notable companies like Abcam and Cambridge CMOS Sensors. The firm continues to explore new fund opportunities, including the potential launch of Martlet Capital Fund II and Martlet Growth Fund for follow-on investments.
What are Martlet Capital's investment criteria?
Martlet Capital invests in pre-seed and seed stage companies primarily in the deep technology and life sciences sectors. They look for startups with strong intellectual property, a capable founding team, and significant growth potential.
How can I apply or pitch to Martlet Capital?
Interested parties can submit a short slide deck summarizing their investment opportunity via email to contactus@martletcap.com. The firm encourages concise presentations that highlight key aspects of the business.
What makes Martlet Capital different from other VCs?
Martlet Capital focuses specifically on deep technology and life sciences, leveraging its strong network and operational support to help startups navigate the complexities of scaling innovative technologies.
What is the geographic scope of Martlet Capital's investments?
The firm primarily invests in the United Kingdom, with a particular emphasis on the Cambridge ecosystem, which is known for its concentration of deep tech and life sciences startups.
What is the typical check size for investments?
Martlet Capital typically invests starting at £250,000, depending on the specific needs and potential of the startup.
What kind of post-investment involvement does Martlet Capital have?
Martlet Capital provides strategic guidance, access to its network, and operational support to help portfolio companies scale effectively. This involvement can include board representation and ongoing mentorship.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.